# ![@MainzBioMed Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1456548800416256008.png) @MainzBioMed Mainz BioMed (NASDAQ: MYNZ)

Mainz BioMed (NASDAQ: MYNZ) posts on X about nasdaq, $mynz, $nasdaq, science the most. They currently have [-----] followers and [--] posts still getting attention that total [---------] engagements in the last [--] hours.

### Engagements: [---------] [#](/creator/twitter::1456548800416256008/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456548800416256008/c:line/m:interactions.svg)

- [--] Week [---------] +816%
- [--] Month [----------] +457,546%
- [--] Months [----------] +22,887%
- [--] Year [----------] +31%

### Mentions: [--] [#](/creator/twitter::1456548800416256008/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456548800416256008/c:line/m:posts_active.svg)

- [--] Week [--] -50%
- [--] Month [--] -14%
- [--] Months [--] +189%
- [--] Year [--] +75%

### Followers: [-----] [#](/creator/twitter::1456548800416256008/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456548800416256008/c:line/m:followers.svg)

- [--] Week [-----] +0.90%
- [--] Month [-----] +4.30%
- [--] Months [-----] +13%
- [--] Year [-----] +17%

### CreatorRank: [------] [#](/creator/twitter::1456548800416256008/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456548800416256008/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[exchanges](/list/exchanges)  #15 [currencies](/list/currencies)  29.73% [finance](/list/finance)  17.57% [stocks](/list/stocks)  #134 [countries](/list/countries)  13.51% [travel destinations](/list/travel-destinations)  2.7%

**Social topic influence**
[nasdaq](/topic/nasdaq) #2, [$mynz](/topic/$mynz) #1, [$nasdaq](/topic/$nasdaq) #14, [science](/topic/science) 9.46%, [health](/topic/health) 8.11%, [ai](/topic/ai) 6.76%, [switzerland](/topic/switzerland) 5.41%, [athome](/topic/athome) 4.05%, [germany](/topic/germany) 4.05%, [stockmarket](/topic/stockmarket) 4.05%

**Top accounts mentioned or mentioned by**
[@myesmo](/creator/undefined) [@onclive](/creator/undefined) [@ernestlancaste7](/creator/undefined)

**Top assets mentioned**
[Mainz Biomed N.V. (MYNZ)](/topic/$mynz) [Thermo Fisher Scientific Inc. (TMO)](/topic/$tmo)
### Top Social Posts
Top posts by engagements in the last [--] hours

"NASDAQ:$MYNZ 📈 Discover the Future of Cancer Detection"  
[X Link](https://x.com/MainzBioMed/status/2014746456184520992)  2026-01-23T17:06Z [----] followers, 13.8M engagements


"At Mainz Biomed we dont just study disease. We research innovate and create non-invasive tests to detect cancer early. $MYNZ $Nasdaq #Health #research"  
[X Link](https://x.com/MainzBioMed/status/2009623343322759430)  2026-01-09T13:48Z [----] followers, [----] engagements


"Mainz Biomed will be part of AACR [----] presenting results from our Pancreatic Cancer Verification Study a key step toward transforming early detection of pancreatic cancerusing a blood-based mRNA signature. 📌San Diego April [----] Read more: $MYNZ $NASDAQ #AACR #PancreaticCancer #artificial_intelligence #Science #UnitedStates https://mainzbiomed.com/mainz-biomed-to-present-results-of-pancreatic-cancer-verification-study-at-aacr-2026-annual-meeting/ https://mainzbiomed.com/mainz-biomed-to-present-results-of-pancreatic-cancer-verification-study-at-aacr-2026-annual-meeting/"  
[X Link](https://x.com/MainzBioMed/status/2011442635324411926)  2026-01-14T14:17Z [----] followers, [----] engagements


"What You Eat Shapes Colorectal Health ✔ More fiber & calcium ❌ Less processed foods Small daily choices support a healthier gut and lower risk. At Mainz Biomed we make prevention easy with awareness healthy habits and accessible early detection tools. #Healthcare #HealthyHabits #Nutrition #Awareness #CancerResearch $MYNZ $Nasdaq https://twitter.com/i/web/status/2013602821967331607 https://twitter.com/i/web/status/2013602821967331607"  
[X Link](https://x.com/MainzBioMed/status/2013602821967331607)  2026-01-20T13:21Z [----] followers, [---] engagements


"Colorectal cancer is preventable but nearly 50% of Europeans aged [----] arent screened. At-home non-invasive tests remove barriers: ✔ Earlier detection ✔ Higher engagement ✔ More lives saved #cancer #cancerresearch #Health #ScienceWorkingLife #Science"  
[X Link](https://x.com/MainzBioMed/status/2016141344624746757)  2026-01-27T13:28Z [----] followers, [---] engagements


"🗞 NEWS RELEASE $MYNZ announced today the appointment of Jane Edwards CCRA RAC as VP of Clinical Affairs. Ms. Edwards will manage the design and logistical operations of $MYNZ clinical trials in the US and Europe to support #FDA submission. News ➡ https://smallcapcomm.com/3MSYbQO https://smallcapcomm.com/3MSYbQO"  
[X Link](https://x.com/MainzBioMed/status/1536717804333895681)  2022-06-14T14:30Z [----] followers, [--] engagements


"🗞 NEWS RELEASE Mainz Biomed N.V. (NASDAQ: $MYNZ) and Dante Genomics a global leader in genomics and precision medicine announced the formal commencement of ColoAlerts consumer commercial program in Italy and the United Arab Emirates (UAE). News 👉 https://smallcapcomm.com/3CaeuXF https://smallcapcomm.com/3CaeuXF"  
[X Link](https://x.com/MainzBioMed/status/1559596364421636097)  2022-08-16T17:42Z [----] followers, [--] engagements


"Thank you to all visitors at @myESMO for engaging in thought-provoking conversations at our booth. Your active participation and dedication to discussing #coloncancer #prevention reaffirmed our mission's significance of raising awareness about this crucial health issue. #wgic2023"  
[X Link](https://x.com/MainzBioMed/status/1678656938425327616)  2023-07-11T06:50Z [----] followers, [---] engagements


"Join Mainz Biomed at the International Conference on Gastroenterology as we unveil groundbreaking findings from our ColoFuture study"  
[X Link](https://x.com/MainzBioMed/status/1707013638941278385)  2023-09-27T12:45Z [----] followers, [---] engagements


"Global cancer rates in those under [--] are on the rise particularly early-onset colorectal cancer from [----] to [----] leading to a concerning increase in related deaths. Early detection and prevention are crucial"  
[X Link](https://x.com/MainzBioMed/status/1707681307386356030)  2023-09-29T08:58Z [----] followers, [---] engagements


"Join us in Miami Beach for insightful discussions about the future of healthcare and biotech innovation. Let's connect collaborate and drive innovation in healthcare"  
[X Link](https://x.com/MainzBioMed/status/1709908917071810843)  2023-10-05T12:30Z [----] followers, [---] engagements


"Dicover the invaluable insights shared by our CEO Guido Baechler as he elucidates the importance of early colon cancer detection using a user-friendly at-home screening test"  
[X Link](https://x.com/MainzBioMed/status/1711755905421672917)  2023-10-10T14:49Z [----] followers, [---] engagements


"Mainz Biomed at UEG Week [----] Join us in Copenhagen Oct 14-17 Hall C Stand C3-92. Discover ColoAlert for early cancer detection. Let's connect and advance gastroenterology together"  
[X Link](https://x.com/MainzBioMed/status/1712378851383251016)  2023-10-12T08:05Z [----] followers, [--] engagements


"Mainz Biomed Welcomes Tarrin Khairi-Taraki as VP of Commercial Operations With a proven track record in the medical diagnostic field Tarrin is set to accelerate the success of ColoAlert in the European market. Learn more about our exciting journey"  
[X Link](https://x.com/MainzBioMed/status/1717858066551459895)  2023-10-27T10:57Z [----] followers, [---] engagements


"Mainz Biomed and Zller-Kipper's BGM (betriebliches Gesundheitsmanagement) CRC Screening Campaign Surpasses All Expectations With Almost Half of Employees Participating A Major Milestone in Employee Health and Early Detection"  
[X Link](https://x.com/MainzBioMed/status/1720101073686294729)  2023-11-02T15:30Z [----] followers, [---] engagements


"Exciting news Our ColoAlert test is making waves with its novel mRNA biomarkers showcasing impressive sensitivity and specificity in detecting colorectal cancer. A big thank you to @OncLive for featuring our groundbreaking work Read more here:"  
[X Link](https://x.com/MainzBioMed/status/1720422558418206745)  2023-11-03T12:47Z [----] followers, [---] engagements


"Mainz Biomed is proud to represent innovation at MEDICA Meet our VP Commercial Operations Tarrin Khairi-Taraki as he showcases ColoAlert - our game-changing CRC detection solution. Join us in Hall [--] Booth F80 and let's discuss early cancer detection"  
[X Link](https://x.com/MainzBioMed/status/1721906863485440508)  2023-11-07T15:06Z [----] followers, [---] engagements


"Mainz Biomed announces positive topline results of eAArly DETECT demonstrating [--] % sensitivity and [--] % specificity for colorectal cancer. Advanced Adenoma sensitivity was reported at [--] %. Exciting times ahead in the field of #CRC screening"  
[X Link](https://x.com/MainzBioMed/status/1732061694401089638)  2023-12-05T15:37Z [----] followers, [---] engagements


"Our eAArly DETECT and ColoFuture study read-outs represent an outstanding result for our Company as well as for CRC disease treatment: A reliable diagnostic test that could not only identify CRC early but also advanced adenoma"  
[X Link](https://x.com/MainzBioMed/status/1732419505572212955)  2023-12-06T15:19Z [----] followers, [---] engagements


"In our #YearEndReview we proudly looked back on our achievements in [----] most prominently the groundbreaking findings from our ColoFuture and eAArly DETECT studies demonstrating superior sensitivity and specificity in #CRC as well as advanced adenoma detection"  
[X Link](https://x.com/anyuser/status/1744753253080870986)  2024-01-09T16:09Z [--] followers, [--] engagements


"JJ Singleton's story shows that bowel cancer isn't bound by age or fitness. The first symptoms of #colorectalcancer should not be ignored. Routine screenings are the key to catching CRC early. ColoAlert simplifies the screening process making it accessible for everyone"  
[X Link](https://x.com/MainzBioMed/status/1746881676439863427)  2024-01-15T13:07Z [----] followers, [---] engagements


"Young individuals are facing challenges confronting crc. The message is clear: the signs of #colorectalcancer can manifest early and should never be dismissed. Early detection is crucial and routine screenings play a pivotal role. ColoAlert simplifies the screening process making it accessible for everyone"  
[X Link](https://x.com/MainzBioMed/status/1750138856542703870)  2024-01-24T12:49Z [----] followers, [---] engagements


"NASDAQ: $MYNZ 📈 Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 97% with Specificity of 97% and Advanced Adenoma Sensitivity of 82% These Results are off the charts and position the company well for its path through a pivotalFDAtrial. 📈"  
[X Link](https://x.com/MainzBioMed/status/1755272680926810274)  2024-02-07T16:49Z [----] followers, 5.8M engagements


"Mainz Biomed and #TomaLab team up to bring ColoAlert to Italy elevating cancer detection. A leap in healthcare innovation saving lives. #FightCancer #HealthInnovation #Investing #Trading $MYNZ"  
[X Link](https://x.com/MainzBioMed/status/1760298545100333429)  2024-02-21T13:40Z [----] followers, [----] engagements


"Mainz Biomed expands ColoAlert access in Germany by partnering with Praxisdienst enhancing the availability of this advanced colorectal cancer test. #EarlyDetection #MainzBiomedPartnership $MYNZ More details:"  
[X Link](https://x.com/MainzBioMed/status/1760659094321451328)  2024-02-22T13:33Z [----] followers, 119.4K engagements


"Showcasing ColoAlert at Gynecology Congress Stuttgart Gynecologists are key in CRC prevention. Our goal: to revolutionize CRC screening making it more comprehensive with ColoAlert. #GynCongress2024 $MYNZ #Investing"  
[X Link](https://x.com/MainzBioMed/status/1762476116915196051)  2024-02-27T13:53Z [----] followers, [---] engagements


"$MYNZ NEW STUDY DATA: Our topline results from our pooled clinical study shows 92% sensitivity for CRC 82% for advanced adenomas setting new diagnostic standards 🧬 More details soon at a major Q2 [----] medical conference. #MainzBiomed #CancerDetection https://mainzbiomed.com/mainz-biomed-reports-positive-topline-results-from-pooled-study-evaluating-novel-mrna-biomarkers-and-proprietary-ai-algorithm-for-integration-into-pivotal-fda-pma-clinical-trial-for-next-generation-co/"  
[X Link](https://x.com/MainzBioMed/status/1783499552563122406)  2024-04-25T14:13Z [----] followers, 65.4K engagements


"$MYNZ Catch us at #DDW2024 for insights into our eAArly DETECT study demonstrating a [--] % accuracy in CRC detection and a remarkable industry-leading [--] % sensitivity for advanced adenomas. Join us on May [--] 12:30 PM EDT. #eAArlyDETECT #trading https://mainzbiomed.com/mainz-biomed-to-present-results-of-colorectal-cancer-screening-study-eaarly-detect-at-digestive-disease-week-2024-in-washington-d-c/ https://mainzbiomed.com/mainz-biomed-to-present-results-of-colorectal-cancer-screening-study-eaarly-detect-at-digestive-disease-week-2024-in-washington-d-c/"  
[X Link](https://x.com/MainzBioMed/status/1787835129500430832)  2024-05-07T13:21Z [----] followers, 100.5K engagements


"$MYNZ #DDW2024 honors Mainz Biomed with Poster of Destinction Award for eAArly DETECTS remarkable study outcome: [--] % CRC & an industry-leading [--] % AA sensitivity. See how we lead the shift from detection to prevention. https://mainzbiomed.com/mainz-biomed-presented-industry-leading-results-at-digestive-disease-week-97-sensitivity-for-colorectal-cancer-82-for-advanced-precancerous-lesions-positioning-the-company-for-its-planned-fda-trial/"  
[X Link](https://x.com/MainzBioMed/status/1792527831785681303)  2024-05-20T12:08Z [----] followers, 97.9K engagements


"NASDAQ:$MYNZ 📈 Discover the Future of Cancer Detection"  
[X Link](https://x.com/MainzBioMed/status/1793365457686372642)  2024-05-22T19:36Z [----] followers, 13.9M engagements


"$MYNZ: Mainz Biomed presents its largest colorectal cancer screening study at #ASCO2024. 92.3% sensitivity for CRC 82.3% for advanced precancerous lesions. Discover our innovative approach using mRNA FIT and AI. #stockmarketnews #investing https://mainzbiomed.com/mainz-biomed-to-present-new-pooled-colorectal-cancer-screening-data-its-largest-study-to-date-at-asco-2024-annual-meeting/ https://mainzbiomed.com/mainz-biomed-to-present-new-pooled-colorectal-cancer-screening-data-its-largest-study-to-date-at-asco-2024-annual-meeting/"  
[X Link](https://x.com/MainzBioMed/status/1795425662137725368)  2024-05-28T12:03Z [----] followers, 42.6K engagements


"$MYNZ: At ASCO [----] Mainz Biomed presented data showing 92.3% sensitivity for CRC and 82.2% for advanced adenomas. Our test also achieved a 95.8% detection rate for high-grade dysplasia. Discover more. #MainzBiomed #ASCO2024#stockmarketnews #investing https://mainzbiomed.com/mainz-biomed-presented-industry-leading-results-of-its-pooled-study-at-asco-2024/ https://mainzbiomed.com/mainz-biomed-presented-industry-leading-results-of-its-pooled-study-at-asco-2024/"  
[X Link](https://x.com/MainzBioMed/status/1797600386267939315)  2024-06-03T12:05Z [----] followers, 225.2K engagements


"$MYNZ submits FDA Breakthrough Device Designation for its Next Gen CRC test supported by consistently excellent clinical data. This designation expedites the development and review for devices addressing serious conditions. #stockmarketnews #investing"  
[X Link](https://x.com/MainzBioMed/status/1810603658666471924)  2024-07-09T09:15Z [----] followers, [----] engagements


"Petra Smeltzer Starke Joins Mainz Biomed to Lead the Charge in Early Detection of Colon Cancer Were thrilled to welcome Petra Smeltzer Starke to the Mainz Biomed team With her incredible experiencefrom advising in the White House to working with global leadersPetra will help us raise awareness about one of the most critical health priorities: early detection of colon cancer. Catching colon cancer early can make all the difference. Our innovative screening tools aim to find the disease in its earliest stages when its most treatable. With Petra on our side were working to make sure more people"  
[X Link](https://x.com/MainzBioMed/status/1836750921759363434)  2024-09-19T12:55Z [----] followers, [----] engagements


"Mid-Year Update from Mainz Biomed: 4% revenue growth 32% decrease in operating losses. Groundbreaking eAArly DETECT study presented at Digestive Disease Week [----] shows 97% CRC sensitivity. Enhanced ColoAlert delivers faster more accurate results. Strategic Plans for 2025: Expand ColoAlert across Europe. Develop next-gen colorectal cancer screening. Launch a 2000-patient U.S. study (eAArly DETECT 2) for breakthrough FDA submission. Read the full press release: $MYNZ #StockMarketNews #StockMarketToday #Investing #Nasdaq #Growth #Biotech #InvestorOpportunity"  
[X Link](https://x.com/MainzBioMed/status/1848335757020156117)  2024-10-21T12:09Z [----] followers, [----] engagements


"Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets Learn more : $TMO $MYNZ #StockMaketNews #Nasdaq #GrowthStock #Biotech #undervalued https://mainzbiomed.com/mainz-biomed-and-thermo-fisher-scientific-sign-a-collaboration-agreement-for-the-development-of-next-generation-colorectal-cancer-screening-product-for-global-markets/"  
[X Link](https://x.com/MainzBioMed/status/1856340031218077732)  2024-11-12T14:15Z [----] followers, [----] engagements


"$MYNZ Mainz Biomed announces a stock split effective Dec. [--] [----] to increase market price meet Nasdaq standards and enhance investor appeal. Read the full press release: #StockMarketNews #StockMarketToday #StockUpdate #stocksplit #investor #investoropportunity #nasdaq #growthstock #Nasdaq #Biotech #investing https://mainzbiomed.com/mainz-biomed-announces-stock-split/ https://mainzbiomed.com/mainz-biomed-announces-stock-split/ https://mainzbiomed.com/mainz-biomed-announces-stock-split/ https://mainzbiomed.com/mainz-biomed-announces-stock-split/"  
[X Link](https://x.com/MainzBioMed/status/1862494054656643133)  2024-11-29T13:49Z [----] followers, [----] engagements


"Mainz Biomed partners with Quest Diagnostics for clinical trials of its FDA-validation colorectal cancer test. Learn more: $MYNZ $DGX #StockMarket #StockMarketUpdate #Investors #Investoropportunity #FDA #GrowthStock #Biomed https://mainzbiomed.com/mainz-biomed-forms-agreement-with-quest-diagnostics-to-provide-clinical-trials-laboratory-services-for-colorectal-cancer-screening-test/ https://mainzbiomed.com/mainz-biomed-forms-agreement-with-quest-diagnostics-to-provide-clinical-trials-laboratory-services-for-colorectal-cancer-screening-test/"  
[X Link](https://x.com/MainzBioMed/status/1869732252562690145)  2024-12-19T13:11Z [----] followers, [----] engagements


"Mainz Biomed initiates the eAArly DETECT [--] U.S. study to evaluate its next-gen test for advanced adenomas in [----] average-risk patients. Enrollment ends mid-2025 with results expected in Q4 [----]. Learn more: $MYNZ #StockMarket #StockAlert #GrowthStock #investor #Biomed #InvestorOpportunity https://mainzbiomed.com/mainz-biomed-initiates-u-s-clinical-study-to-evaluate-performance-of-next-generation-test-on-advanced-adenomas-over-large-patient-population/"  
[X Link](https://x.com/MainzBioMed/status/1881690576208187571)  2025-01-21T13:09Z [----] followers, [----] engagements


"This March we stand against colorectal cancer. Early detection saves lives. With accessible at-home testing we help more people get tested because every life is worth protecting. Learn more: #Cancer #CancerAwareness #cancerai #Science #innovation #coloncancer #CRC #Awareness #Biomed #Health #research #earlydetection https://mainzbiomed.com/colorectal-cancer-awareness-month-mainz-biomed-advocates-for-a-shift-from-screening-to-prevention/ https://mainzbiomed.com/colorectal-cancer-awareness-month-mainz-biomed-advocates-for-a-shift-from-screening-to-prevention/"  
[X Link](https://x.com/MainzBioMed/status/1896547435192750558)  2025-03-03T13:05Z [----] followers, [---] engagements


"Mainz Biomed & Liquid Biosciences announce groundbreaking discovery of mRNA biomarkers for blood-based detection of #pancreatic cancer. 🧪Discovery analysis: 95% sensitivity AND 98% specificity 📄 Mainz Biomed signs exclusive license & option agreement for the biomarker portfolio paving the way for future #FDA applications. Learn more: $MYNX #Cancer #Science #Scienceweek #Innovation #Health #StockMarket #StockMarket #StocksToWatch #Investor #GrowthStocks #discovery #bioscience"  
[X Link](https://x.com/MainzBioMed/status/1900155239103189118)  2025-03-13T12:01Z [----] followers, [---] engagements


"Mainz Biomed enrolls the first patient in its eAArly DETECT [--] study. 🔬 2000+ average-risk patients ✅ Validates previous results 🛡 Aims to shift from CRC screening to prevention Supports future U.S. programs 📅 Top-line results expected Q4 [----] Learn more: $MYNZ $Nasdaq #Coloncancer #Cancer #CancerResearch #CancerAwareness #health #artificial_intelligence #UnitedStates #biomedice #Markets #StockMarket #stocks #StocksInFocus #investors #Growth https://mainzbiomed.com/mainz-biomed-enrolls-first-patient-in-its-eaarly-detect-2-clinical-study/"  
[X Link](https://x.com/MainzBioMed/status/1905244466136350917)  2025-03-27T13:04Z [----] followers, 23.8K engagements


"Mainz Biomed [----] Highlights 📈 Lab network revenue increased by 33% year over year. 📉Operating loss decreased by 30% and net loss by 18%. 🤝 New partnerships with Thermo Fisher Quest Diagnostics and Liquid Biosciences 💡Key moments: 📊ASCO 2024: Key colorectal cancer data and 🏆DDW 2024: Poster of Distinction for eAArly DETECT Excited for [----]. Learn more: $Nasdaq $MYNZ $TMO $DGX #StocksToWatch #Stockmarkets #stocks #Stock #cancercolorrectal #Cancer #CancerResearch #Growth #CancerAwareness #health #artificial_intelligence #UnitedStates #biomedice #Markets #StockMarket #stocks #StocksInFocus"  
[X Link](https://x.com/MainzBioMed/status/1907040569949319178)  2025-04-01T12:01Z [----] followers, 47.7K engagements


"Mainz Biomed and EDX Medical have joined forces. 🤝A strategic partnership to bring advanced molecular diagnostics to the UK Learn more: #stocks #investors #stockmarkets #UnitedKingdom #CancerPrevention #Cancer #Health #Medical $Nasdaq $MYNZ https://mainzbiomed.com/mainz-biomed-enters-into-technology-partnership-with-edx-medical-group/ https://mainzbiomed.com/mainz-biomed-enters-into-technology-partnership-with-edx-medical-group/"  
[X Link](https://x.com/MainzBioMed/status/1917188679111467485)  2025-04-29T12:06Z [----] followers, 17.1K engagements


"Mainz Biomed made strong H1 [----] progress in early cancer detection: Launched eAArly DETECT [--] (2000 pts) setting up [----] FDA CRC trial ColoAlert launched in Switzerland (labor team w ag) expanded in UK (EDX Medical) Advanced pancreatic cancer program: licensed Liquid Biosciences mRNA biomarkers (95% sensitivity / 98% specificity) PancAlert feasibility phase underway; backed by public ISB funding Regained #Nasdaq compliance raised $4M Building real momentum into H2. Learn more here: #Cancer #CancerSupport #cancerresearch #healthTech #Biomedical #Innovation #CancerAwareness #InnovationForAll"  
[X Link](https://x.com/MainzBioMed/status/1945093911409467674)  2025-07-15T12:11Z [----] followers, [----] engagements


"Commercial launch achieved: Mainz Biomed rolls out ColoAlert in Switzerland and keeps the eAArly DETECT [--] study on track. Read more here: #Cancer #CancerAwareness #healthTech #Innovation #Research #Health #StockMarket #Growth #MarketAlert $MYNZ $NASDAQ #InvestorAttention https://mainzbiomed.com/mainz-biomed-announces-commercial-launch-of-coloalert-in-switzerland/ https://mainzbiomed.com/mainz-biomed-announces-commercial-launch-of-coloalert-in-switzerland/ https://mainzbiomed.com/mainz-biomed-announces-commercial-launch-of-coloalert-in-switzerland/"  
[X Link](https://x.com/MainzBioMed/status/1970458771047538956)  2025-09-23T12:02Z [----] followers, [--] engagements


"Akey moment in colorectal cancer research On Oct [--] Mainz Biomed will be at the WEO CRC Screening Committee Meeting in Berlin. Dr. Lena Krammes will present findings from the eAArly DETECT study showing how RNA-based stool testing can detect cancer early. Read more: #Cancer #CancerFree #biomedicalresearch #Health #HealthcareForAll #Research #Innovation #StockMarket #StocksToWatch $nasdaq $MYNZ https://mainzbiomed.com/mainz-biomed-to-present-the-future-of-colorectal-cancer-screening-at-weo-crc-screening-committee-meeting/"  
[X Link](https://x.com/MainzBioMed/status/1972996802996514828)  2025-09-30T12:07Z [----] followers, [---] engagements


"Preventing one of the deadliest preventable cancers In partnership with GANZIMMUN Diagnostics our enhanced ColoAlert test is now available across Germany for early detection. Learn more: $MYNZ #StockMarket #investoropportunity #Investor #Innovation #GrowthStock #Growth #Nasdaq #StockAlert #Biomed #Health #Mainz #Deutschland https://mainzbiomed.com/mainz-biomed-and-ganzimmun-announce-launch-of-enhanced-coloalert-colorectal-cancer-screening-ahead-of-awareness-month/"  
[X Link](https://x.com/MainzBioMed/status/1889314287673315655)  2025-02-11T14:03Z [----] followers, 61.1K engagements


"Saving lives through early detection Mainz Biomed partners with Labor Team W AG to introduce ColoAlerta non-invasive DNA-based colorectal cancer screening test in Switzerland. Early detection saves lives. Easier screening = More lives saved. Learn more : $MYNZ #StockMarket #investoropportunity #Investor #Innovation #GrowthStock #Growth #Nasdaq #StockAlert #Biomed #Health #Mainz #Cancer #Switzerland https://mainzbiomed.com/mainz-biomed-expands-into-switzerland-with-labor-team-w/ https://mainzbiomed.com/mainz-biomed-expands-into-switzerland-with-labor-team-w/"  
[X Link](https://x.com/MainzBioMed/status/1892562085550174568)  2025-02-20T13:08Z [----] followers, [----] engagements


"South America Takes the Lead: Mainz Biomed to Introduce ColoAlert in New Regional Markets Mainz Biomed has entered a new phase of international expansion signing an MOU with OncoVanguard8 to bring ColoAlert our DNA-based colorectal cancer screening test to Peru Colombia and Ecuador marking our entry into the South American market. Stay updated and read more here: $NASDAQ $MYNZ #StockMarket #StockMarketNews #InnovationInAction #GrowthStocks #Biomed #CancerResearch https://mainzbiomed.com/mainz-biomed-and-oncovanguard8-enter-into-agreement-to-bring-coloalert-to-south-america/"  
[X Link](https://x.com/MainzBioMed/status/1990792497589526742)  2025-11-18T14:41Z [----] followers, [---] engagements


"This day is particularly challenging as we remember the many individuals and families affected by this devastating disease. Pancreatic cancer is the fourth leading cause of cancer-related deaths in Europe and it has a five-year survival rate of only 9%. Sadly most cases are diagnosed too late making surgery an unavailable option. This is why raising awareness promoting education and encouraging early detection are so crucial. Lets take this month to learn share information and support research that has the potential to change the future of this disease. Together we can bring hope."  
[X Link](https://x.com/MainzBioMed/status/1991502742091690440)  2025-11-20T13:43Z [----] followers, [---] engagements


"Do you know the symptoms of pancreatic cancer Most people dont and thats part of why its so deadly. Pancreatic cancer is the 7th leading cause of cancer death worldwide. Only 1020% of cases are diagnosed early when surgery is an option. Late-stage diagnosis leads to a 5-year survival rate of just 12%"  
[X Link](https://x.com/MainzBioMed/status/1991865122717929942)  2025-11-21T13:43Z [----] followers, [---] engagements


"Currently there is no specific medical test available to detect pancreatic cancer early. 🧬 Diagnosis often relies on imaging scans (CT or MRI) blood tests for tumor markers like CA 19-9 which has a low sensitivity for early stages and biopsies. Thats why at Mainz Biomed we dedicate our research to this cause because developing a simple blood test could truly change the course of this disease and make early detection possible. $MAINZ #healthcare #PancreaticCancer #CancerAwareness #Cancer #news"  
[X Link](https://x.com/MainzBioMed/status/1992963535991623902)  2025-11-24T14:28Z [----] followers, [---] engagements


"Pancreatic cancer can often be diagnosed too late primarily because its symptoms can be vague or easily mistaken for other issues. This November during #PancreaticCancerAwarenessMonth lets take a moment to raise awareness about the signs that you should never ignore. ⚠ Its important to be aware of common symptoms such as: Unexplained weight loss abdominal or back pain jaundice (the yellowing of the skin or eyes) loss of appetite or nausea fatigue or weakness and sudden onset of diabetes. If you notice any of these symptoms especially if youre at higher risk please dont hesitate to reach out"  
[X Link](https://x.com/MainzBioMed/status/1993311545531465873)  2025-11-25T13:31Z [----] followers, [---] engagements


"Pancreatic cancer has a pretty grim 5-year survival rate of just 12% mainly because it's often diagnosed too late. Our feasibility study is diving into the use of mRNA biomarkers combined with AI to spot precancerous and early-stage changes. We're hoping to set a new standard for early detection #PancreaticCancer #Cancer #CancerResearch #CancerAwareness #CancerCare #Medicine #sciencenews"  
[X Link](https://x.com/MainzBioMed/status/1993679012808311037)  2025-11-26T13:51Z [----] followers, [---] engagements


"Pancreatic cancer is known to be one of the deadliest cancers often diagnosed too late for effective treatment. To change this its essential to focus on early detection. The recent results from Mainz Biomed (NASDAQ: MYNZ) highlight a promising step forward: Our first feasibility study shows promising results with outstanding 100% sensitivity and 95% specificity allowing for the accurate and early detection of pancreatic cancer. These findings offer new hope for early diagnosis and prevention in a field that has long grappled with the need for effective screening tools. With innovations like"  
[X Link](https://x.com/MainzBioMed/status/1994042283226747022)  2025-11-27T13:55Z [----] followers, [---] engagements


"Did you know Mainz is one of Europes biotech capitals 🧬 Home to BioNTech TRON Ganymed Schott AG and Johannes Gutenberg University its where science and innovation meet real impact. $BNTX $TRON $MYNZ $NASDAQ #Mainz #Germany #Deutschland $Gutenberg #Univeristy #Innovation #Biotech #Science https://twitter.com/i/web/status/1994401784341684283 https://twitter.com/i/web/status/1994401784341684283"  
[X Link](https://x.com/MainzBioMed/status/1994401784341684283)  2025-11-28T13:43Z [----] followers, [---] engagements


"mRNA biomarkers go beyond carrying genetic messages they reveal when biological processes change. At Mainz Biomed we use [--] novel mRNA biomarkers and AI to detect precancerous polyps and early colorectal cancer. $MYNZ #Biomed #CancerResearch #scienceperspective #Innovation #CancerAwareness https://twitter.com/i/web/status/1995498885930795390 https://twitter.com/i/web/status/1995498885930795390"  
[X Link](https://x.com/MainzBioMed/status/1995498885930795390)  2025-12-01T14:23Z [----] followers, [----] engagements


"✅ eAArly DETECT [--] study progressing ✅ mRNA biomarkers+ FIT test + AI improving early detection ✅ Turning CRC screening into prevention #colorectalcancer #Innovation #researchimpact #AI #CancerResearch #Cancerscreening #HealthcareAI #ArtificialInteligence"  
[X Link](https://x.com/MainzBioMed/status/1996212779515105750)  2025-12-03T13:39Z [----] followers, [---] engagements


"From Detection to Prevention Early Evidence from RNA-based Screening Test for Precancerous Lesions Compared to Different FIT Cut-offs at the WEO in Berlin. Sharing results from the eAArly DETECT [----] study. The data highlights the potential of stool RNA testing to identify both colorectal cancer and precancerous lesions"  
[X Link](https://x.com/MainzBioMed/status/1996936608185041086)  2025-12-05T13:36Z [----] followers, [--] engagements


"From Detection to Prevention Early Evidence from RNA-based Screening Test for Precancerous Lesions Compared to Different FIT Cut-offs at the WEO in Berlin. Sharing results from the eAArly DETECT [----] study. The data highlights the potential of stool RNA testing to identify both colorectal cancer and precancerous lesions. #ColorectalCancer #Cancer #HealthForAll #science"  
[X Link](https://x.com/MainzBioMed/status/1996936978298761707)  2025-12-05T13:37Z [----] followers, [---] engagements


"$MYNZ launches its updated ColoAlert version for CRC screening featuring a new DNA stabilizing buffer which significantly enhances the lab efficiency. Faster results and fewer retests #stockmarketnews #investing https://mainzbiomed.com/mainz-biomed-launches-enhanced-coloalert-with-cutting-edge-features-to-optimize-screening-efficiency-and-user-convenience/ https://mainzbiomed.com/mainz-biomed-launches-enhanced-coloalert-with-cutting-edge-features-to-optimize-screening-efficiency-and-user-convenience/"  
[X Link](https://x.com/MainzBioMed/status/1816456359363203246)  2024-07-25T12:51Z [----] followers, 25.7K engagements


"Do you know when the FIT test was discovered In the 1990s researchers developed the Fecal Immunochemical Test (FIT). A simple non-invasive way to detect hidden blood in stoola key early sign of colorectal cancer. Today ColoAlert takes it further. By adding stool-DNA biomarkers we can detect molecular signs of cancer earlier. Early detection saves lives. #Science #SciencePerspective #Medicine #health #StockMarketNews #Biotech #growthstocks #Investors"  
[X Link](https://x.com/MainzBioMed/status/1998734469692326182)  2025-12-10T12:40Z [----] followers, [---] engagements


"Each year 37M colorectal screenings are performed in the U.S. expected to rise to 52M in [--] years. Still nearly 40% of people [----] remain unscreened 53K deaths annually. Screening at 45+ can save lives. #Cancer #CancerResearch #UnitedStates #Health #Mainz $MAINZ $Nasdaq"  
[X Link](https://x.com/MainzBioMed/status/1999100277090054652)  2025-12-11T12:53Z [----] followers, [---] engagements


"Our eAArly DETECT [--] study isnt just detecting CRC its redefining prevention. Using mRNA biomarkers FIT and AI we can catch precancerous lesions early. Prevention is now proactive & powerful. #ColorectalCancer #CancerScreening #BiotechStocks #MedTechInnovation #biomed #prevention"  
[X Link](https://x.com/MainzBioMed/status/1999468728799416480)  2025-12-12T13:17Z [----] followers, [---] engagements


"Science moves us forward. Every day through research and dedication we build progress in early cancer detection. We envision a world where colorectal cancer diagnosis becomes prevention and every test gives hope for a longer healthier life. #cancer #CancerResearch #CancerCare #HealthcareAI #coloncancer #SciencePerspective #Science #Innovation #ResearchDay2025"  
[X Link](https://x.com/MainzBioMed/status/2000557057724789026)  2025-12-15T13:22Z [----] followers, [---] engagements


"Together with Liquid Biosciences we used their EMERGE AI platform to identify [--] mRNA biomarkers for pancreatic cancer. The lead panel achieved 100% sensitivity and 95% specificity in a 30-subject study #ArtificialIntelligence #CancerResearch #Research #Health #Algorithms #SciencePerspective #innovation2025 $MYNZ $Nasdaq #StocksToWatch"  
[X Link](https://x.com/MainzBioMed/status/2000901400050413750)  2025-12-16T12:10Z [----] followers, [---] engagements


"At Mainz Biomed we believe prevention isnt passive. Its proactive data-driven and transformative. Through the eAArly DETECT [--] study we aim to prove that advanced molecular testing can detect precancerous lesions long before disease develops. This changes everything. Because prevention isnt about waiting its about acting early with precision and purpose. Together we can shift global perception: from detecting cancer to preventing it. #Biotech #Health #HealthTech $MYNZ $NASDAQ #StocksToWatch #stockmarketnews"  
[X Link](https://x.com/MainzBioMed/status/2001286365107962297)  2025-12-17T13:40Z [----] followers, [----] engagements


"Over 112M Americans are 50+ a number projected to reach 157M within the next decade making early detection of colorectal cancer more important than ever. At Mainz Biomed were dedicated to pioneering innovative diagnostic solutions that make colorectal cancer screening simple accurate and accessible for everyone. When testing is within reach prevention becomes a reality. $MYNZ $NASDAQ #stockmarketnews #Stocks #Marketwatch #MarketNews #UnitedStates https://twitter.com/i/web/status/2001634099241304525 https://twitter.com/i/web/status/2001634099241304525"  
[X Link](https://x.com/MainzBioMed/status/2001634099241304525)  2025-12-18T12:42Z [----] followers, [---] engagements


"ColoAlert is registered for use across the UK. Bringing faster results and better access to early cancer detection. #uk #UnitedKingdom #BionTech #StocksToWatch #investors #InvestorAlert #Growth #finance2025"  
[X Link](https://x.com/MainzBioMed/status/2002025628422590856)  2025-12-19T14:38Z [----] followers, [---] engagements


"In the U.S. Mainz Biomed continues advancing our mission in early cancer detection. Our eAArly DETECT [--] study is progressing toward the ReconAAsense FDA pivotal trial for colorectal cancer in [----]. #FDA $MAIZ $NASDAQ #news #BIOTECH #StockMarket #stockmarketnews #Growth #investors"  
[X Link](https://x.com/MainzBioMed/status/2003109640310026556)  2025-12-22T14:25Z [----] followers, [----] engagements


"More and more its becoming clear that what we eat shapes our long-term health especially our colorectal health Consuming higher levels of ultra-processed foods had a greater risk of developing precancerous colorectal polyps early growths that can become cancer if unnoticed. Thats why we created ColoAlert our at-home stool DNA test an at-home stool DNA test to make early detection proactive private and routine. Because prevention shouldnt be difficult. It should fit into real life. #HealthyHabits #health #Nutrition #Cancer #CancerResearch #HealthyLiving #NewsUpdate"  
[X Link](https://x.com/MainzBioMed/status/2005995765210972603)  2025-12-30T13:33Z [----] followers, [----] engagements


"From Mainz Biomed we want to wish everyone a great [----] 🎉 [----] proved whats possible with an exceptional team and strong partners. We: ✅Launched eAArly DETECT 2in the U.S. (2000 patients) 🗺Expanded ColoAlertacross the UK Switzerland & South America ☑Advanced pancreatic cancer screening with 100% sensitivity / 95% specificityin feasibility studies In [----] our focus is clear: complete eAArly DETECT [--] and move ReconAAsense toward FDA approval. Building the future of early cancer detection. Read more: $NASDAQ $MAINZ #stockmarketnews #StocksInFocus #stocks"  
[X Link](https://x.com/MainzBioMed/status/2008181692289396886)  2026-01-05T14:20Z [----] followers, [----] engagements


"Imagine catching colorectal cancer early before its too late. 💡 [----] Ask about at-home screening like ColoAlert. 💡Work in healthcare HR or wellbeing Help raise awareness. Early detection saves lives. Together prevention is possible. #Cancer #CancerResearch #Science $NASDAQ $MYNZ https://twitter.com/i/web/status/2012154001429573972 https://twitter.com/i/web/status/2012154001429573972"  
[X Link](https://x.com/MainzBioMed/status/2012154001429573972)  2026-01-16T13:24Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing